Loramyc Articles

BioAlliance Pharma pursues development plan for Loramyc in Japan through partner Sosei

13 March 2013

BioAlliance says partner Vestiq debuts Oravig in USA

8 January 2013

BioAlliance Pharma out-licenses Oravig to Vestiq Pharma for the USA

22 July 2012

BioAlliance Pharma files appeal to the French Supreme Court contesting decision on SpePharm and SpeBio

8 June 2011

BioAlliance licenses European commercialization rights for Loramyc and Setofilm to Therabel in a 48.5 million-euro deal

7 April 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end